Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases in vitro and in vivo differentiation: A possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages

被引:35
作者
Lewin, SR [1 ]
Lambert, P [1 ]
Deacon, NJ [1 ]
Mills, J [1 ]
Crowe, SM [1 ]
机构
[1] MACFARLANE BURNET CTR MED RES,NATL CTR HIV VIROL RES,FAIRFIELD,VIC 3078,AUSTRALIA
关键词
D O I
10.1128/JVI.71.3.2114-2119.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in vitro in differentiated macrophages than in freshly isolated monocytes. We investigated whether this may be partly explained by changes in expression of NF-kappa B with monocyte differentiation. We demonstrated that constitutive expression of NF-kappa B in primary human monocytes changed significantly with differentiation in vitro to monocyte-derived macrophages (MDMs) and differentiation in vivo to alveolar macrophages (AMs). Freshly isolated monocytes constitutively expressed high levels of transcriptionally inactive p50 homodimer which decreased with time in culture in favor of the transcriptionally active p50/p65 and p50/RelB heterodimers. As in MDMs, AMs constitutively expressed p50/p65 and p50/RelB although at lower levels. HIV infection of fresh monocytes failed to induce p50/p65 as seen in MDMs. The replacement of p50 homodimers with transcriptionally active heterodimers following time in culture may partially explain the progressive increase in susceptibility of monocytes to HIV infection during in vitro culture. The change in NF-kappa B components with monocyte differentiation in vivo may also explain the different transcriptional activities of these cell populations in HIV-infected individuals.
引用
收藏
页码:2114 / 2119
页数:6
相关论文
共 42 条
  • [1] HIV ENHANCER ACTIVITY PERPETUATED BY NF-KAPPA-B INDUCTION ON INFECTION OF MONOCYTES
    BACHELERIE, F
    ALCAMI, J
    ARENZANASEISDEDOS, F
    VIRELIZIER, JL
    [J]. NATURE, 1991, 350 (6320) : 709 - 712
  • [2] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [3] THE 65-KDA SUBUNIT OF HUMAN NF-KAPPA-B FUNCTIONS AS A POTENT TRANSCRIPTIONAL ACTIVATOR AND A TARGET FOR V-REL-MEDIATED REPRESSION
    BALLARD, DW
    DIXON, EP
    PEFFER, NJ
    BOGERD, H
    DOERRE, S
    STEIN, B
    GREENE, WC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) : 1875 - 1879
  • [4] THE NF-KAPPA-B BINDING-SITE IS NECESSARY FOR EFFICIENT REPLICATION OF SIMIAN IMMUNODEFICIENCY VIRUS OF MACAQUES IN PRIMARY MACROPHAGES BUT NOT IN T-CELLS INVITRO
    BELLAS, RE
    HOPKINS, N
    LI, Y
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (05) : 2908 - 2913
  • [5] CHURCHILL MR, COMMUNICATION
  • [6] QUANTITATIVE IMMUNOCYTOFLUOROGRAPHIC ANALYSIS OF CD4 SURFACE-ANTIGEN EXPRESSION AND HIV-INFECTION OF HUMAN PERIPHERAL-BLOOD MONOCYTE MACROPHAGES
    CROWE, S
    MILLS, J
    MCGRATH, MS
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1987, 3 (02) : 135 - 145
  • [7] THE CANDIDATE ONCOPROTEIN BCL-3 IS AN ANTAGONIST OF P50/NF-KAPPA-B-MEDIATED INHIBITION
    FRANZOSO, G
    BOURS, V
    PARK, S
    TOMITAYAMAGUCHI, M
    KELLY, K
    SIEBENLIST, U
    [J]. NATURE, 1992, 359 (6393) : 339 - 342
  • [8] A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTIC CELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS
    FRANZOSO, G
    BISWAS, P
    POLI, G
    CARLSON, LM
    BROWN, KD
    TOMITAYAMAGUCHI, M
    FAUCI, AS
    SIEBENLIST, UK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1445 - 1456
  • [9] THE ONCOPROTEIN BCL-3 CAN FACILITATE NF-THETA-B-MEDIATED TRANSACTIVATION BY REMOVING INHIBITING P50 HOMODIMERS FROM SELECT THETA-B SITES
    FRANZOSO, G
    BOURS, V
    AZARENKO, V
    PARK, S
    TOMITAYAMAGUCHI, M
    KANNO, T
    BROWN, K
    SIEBENLIST, U
    [J]. EMBO JOURNAL, 1993, 12 (10) : 3893 - 3901
  • [10] THE ROLE OF MONONUCLEAR PHAGOCYTES IN HTLV-III LAV INFECTION
    GARTNER, S
    MARKOVITS, P
    MARKOVITZ, DM
    KAPLAN, MH
    GALLO, RC
    POPOVIC, M
    [J]. SCIENCE, 1986, 233 (4760) : 215 - 219